{
    "ticker": "ONTF",
    "name": "OncoOne, Inc.",
    "description": "OncoOne, Inc. is a biotechnology company focused on developing innovative therapies for cancer treatment. Founded in 2015, the company is dedicated to transforming the landscape of oncology through its proprietary drug candidates that target the unique biology of cancer cells. OncoOne's lead product candidate, a novel protein-based therapeutic agent, is designed to inhibit the progression of various types of cancer by targeting the underlying mechanisms that drive tumor growth and metastasis. The company's research is rooted in a deep understanding of cancer biology, aiming to provide safer and more effective treatment options for patients. OncoOne is committed to advancing its clinical programs while collaborating with leading research institutions and medical experts. The company's mission is to improve patient outcomes and quality of life by delivering groundbreaking cancer therapies that address critical unmet medical needs in oncology. With a strong pipeline of drug candidates and a focus on clinical development, OncoOne is positioned to make significant contributions to the fight against cancer.",
    "industry": [
        "Biotechnology",
        "Pharmaceuticals"
    ],
    "headquarters": "Boulder, Colorado, USA",
    "founded": "2015",
    "website": "https://www.oncoone.com",
    "ceo": "Jeffrey S. D. Dorsey",
    "social_media": {
        "twitter": "https://twitter.com/OncoOne",
        "linkedin": "https://www.linkedin.com/company/oncoone"
    },
    "investor_relations": "https://www.oncoone.com/investors",
    "key_executives": [
        {
            "name": "Jeffrey S. D. Dorsey",
            "position": "CEO"
        },
        {
            "name": "David A. Dyer",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Cancer Therapies",
            "products": [
                "OncoOne Lead Product Candidate"
            ]
        }
    ],
    "seo": {
        "meta_title": "OncoOne, Inc. | Innovative Cancer Therapies",
        "meta_description": "OncoOne, Inc. is a biotechnology company dedicated to developing innovative therapies for cancer treatment. Learn about our groundbreaking research and pipeline.",
        "keywords": [
            "OncoOne",
            "Biotechnology",
            "Cancer Treatment",
            "Pharmaceuticals",
            "Oncology",
            "Innovative Therapies"
        ]
    },
    "faq": [
        {
            "question": "What does OncoOne focus on?",
            "answer": "OncoOne focuses on developing innovative therapies for cancer treatment."
        },
        {
            "question": "Who is the CEO of OncoOne?",
            "answer": "Jeffrey S. D. Dorsey is the CEO of OncoOne, Inc."
        },
        {
            "question": "Where is OncoOne headquartered?",
            "answer": "OncoOne is headquartered in Boulder, Colorado, USA."
        },
        {
            "question": "What is OncoOne's lead product candidate?",
            "answer": "OncoOne's lead product candidate is a novel protein-based therapeutic agent targeting cancer biology."
        },
        {
            "question": "When was OncoOne founded?",
            "answer": "OncoOne was founded in 2015."
        }
    ],
    "competitors": [
        "AMGN",
        "BMY",
        "NVS",
        "REGN"
    ],
    "related_stocks": [
        "GILD",
        "VRTX",
        "ABBV",
        "MRNA"
    ]
}